MindWalk shares surge 13.24% premarket after identifying functional constraint in influenza viruses, advancing universal flu program.

MindWalk (HYFT) surged 13.24% in premarket trading following announcements of progress in its universal influenza program. The company identified a functional constraint in influenza viruses that persists across strains, potentially enabling the development of more effective therapeutics. Two related news events highlighted this breakthrough, emphasizing its significance for advancing universal influenza treatments. The premarket rally aligns with the positive implications of these scientific advancements for the company’s research pipeline and long-term growth prospects.